The Federal Trade Commission (FTC) and attorneys general in four states filed a lawsuit Wednesday against the World Professional Association for Transgender Health (WPATH), accusing the group of misleading doctors, parents, and children to promote the lucrative business of administering transgender procedures to minors. In a 123-page complaint, the FTC lays out “ten specific unlawful misrepresentations or omissions” by WPATH and seeks “a permanent injunction to prevent future violations.”

“When an organization provides guidance designed to mislead families about the risks, benefits, or medical consensus behind a treatment, it undermines trust in those responsible for providing medical care,” declared FTC Commissioner Mark R. Meador. The FTC was joined in its lawsuit by attorneys general from Alaska, Iowa, Nebraska, and Texas.

The lawsuit is significant because it goes directly to the source of claims undergirding transgender medical practice. In countless other legal battles, pro-transgender activists have invariably cited WPATH as the foremost authority on transgender procedures for minors. Now, the FTC has challenged WPATH itself to prove that its claims, often cited as an expert authority, can hold up in a court of law.

The lawsuit challenged the accuracy of specific claims made by WPATH, as well as omissions in the most recent version of its so-called, unofficial “Standards of Care” (SOC-8):

“(1) WPATH misrepresents that pediatric medical transition is medically necessary to prevent suicide in children who express dissatisfaction with or report distress about their sex traits.

“(2) WPATH misrepresents that pediatric medical transition is effective at preventing suicide in children who express dissatisfaction with or report distress about their sex traits.

“(3) WPATH misrepresents that puberty blockers are fully reversible.

“(4) WPATH misrepresents that cross-sex hormones improve mental health.

“(5) WPATH misrepresents that performing breast amputations on children is safe, effective, and consistently results in better health and quality of life.

“(6) WPATH misrepresents SOC-8 to be the result of unbiased, evidence-based expert consensus.

“(7) WPATH misrepresents that pediatric medical transition is the “standard of care” for children who express dissatisfaction with or report distress about their sex traits.

“(8) WPATH fails in SOC-8 to adequately disclose certain side effects of puberty blockers including hot flashes, lethargy, and cognitive problems.

“(9) WPATH fails in SOC-8 to adequately disclose certain side effects of cross-sex hormones including mood disturbances, vocal pain, pelvic pain, pelvic floor dysfunction, clitoral discomfort, vaginal pain, persistent sexual dysfunction continuing after cessation of use, and erectile pain.

“(10) WPATH fails in SOC-8 to adequately disclose certain side effects of breast amputations including inability to breastfeed, nerve damage, and necrosis of the nipples.”

“WPATH made each of these ten misrepresentations or omissions expressly or by implication,” the complaint declared. “WPATH knew they were false or misleading, and WPATH further knew — and intended — that they would provide WPATH members and other providers of medical transition services with the means to mislead consumers.”

The FTC challenged WPATH’s SOC-8 in detail, alleging that its methodology “does not satisfy accepted medical standards of evidence” for at least four reasons. “WPATH selected authors who had conflicts of interest; WPATH ignored the consensus protocol that SOC-8 purports to follow; WPATH failed to adhere to proper protocols both in evaluating scientific and medical evidence and in making recommendations based on that evidence; and WPATH made material changes to its recommendations in response to external pressure rather than scientific evidence.”

Regarding conflicts of interest, the FTC argued that WPATH selected drafters for SOC-8 who had both “intellectual conflicts of interest” and “financial … conflicts of interest.” The intellectual conflicts of interest stemmed from the fact that its selection criteria required every team leader to be a “longstanding WPATH Full Member in good standing” and a “well recognized advocate for WPATH” — in other words, professionals “who already supported medical transition services.”

The financial conflicts of interest concerned the fact that many authors directly performed and thereby profited from the procedures under review, such as Dr. Marci Bowers. Bowers, the complaint stated, “made more than a million dollars in a single year from transition surgeries but declared it ‘absurd’ to disclose that conflict or attempt to account for it in SOC-8.”

Regarding external pressure, the FTC referenced “the removal of age minimums for pediatric medical transition drugs, surgeries, and services including cross-sex hormones, breast amputations, surgical penis removal, and facial surgery.” This removal came after the Biden administration Department of Health and Human Services asked in 2022 “if the specific ages can be taken out” to combat “the conservative anti trans agenda.” In addition, “According to a WPATH leader, the American Academy of Pediatrics threatened to ‘actively publicly oppose’ SOC-8 if WPATH did not remove the age minimums,” although without “any sound evidence-based argument(s) underpinning” the change it demanded.

“One WPATH committee member acknowledged that it was ‘the most strange experience’ to see WPATH eliminate minimum age recommendations at the ‘last minute’ after internal discussion made clear that ‘nobody [on the committee] wanted to [eliminate] them, and personally not agreeing with the change,’” the complaint stated.

Regarding consensus protocol, the FTC elaborated on the same issue, noting that WPATH failed to strictly follow its own selected “Delphi process” for achieving expert consensus. “At least one WPATH member could not ‘see how we can simply remove something that important from the document — without going through a Delphi — at this final stage of the game.’”

Regarding the quality of evidence, the FTC excoriated WPATH for “a deliberate decision to obfuscate the strength of the evidence supporting WPATH’s recommendations and allow WPATH to overstate the strength of its evidence.” WPATH claimed to use an evidence-rating system called “GRADE,” but it chose not to include the GRADE ratings to make the evidence look stronger than it really was. One draft leader, Dr. Eli Coleman, admitted in 2023, “[a]ll of us are painfully aware that there are many gaps in research to back up our recommendations.”

Yet the SOC-8 authors “knew ‘what we should end up with,’” the complaint alleged, because “SOC-8 authors had prejudged that SOC-8 would ultimately make strong recommendations in favor of pediatric medical transition regardless of whether the quality of the evidence supported such recommendations.” As one author, Dr. Amy Tishelman, said in February 2026, “The sun and the moon existed before we understood anything about why. Lots of things we observe in life, we know to be true, and we don’t understand them.”

The complaint goes on to argue that WPATH failed to “follow the science” in other important respects. For instance, “SOC-8’s authors commissioned systematic reviews of evidence regarding pediatric medical transition from Johns Hopkins University,” according to the complaint. However, “WPATH secured significant control over … they would ultimately be published.” When the reviews “found little to no evidence about children and adolescents,” “WPATH rejected multiple Johns Hopkins manuscripts, causing” the head of the research team “to express frustration that WPATH was ‘trying to restrict our ability to publish.’”

The incident echoes the 2024 controversy involving Dr. Johanna Olson-Kennedy, later head of USPATH (WPATH’s American outpost), who refused to publish the results of a taxpayer-funded study after they contradicted her belief in using puberty blockers for the purpose of gender transition. The complaint referenced another “notable evidentiary exclusion” involving Olson-Kennedy. Although a study she conducted “formed the evidence base of SOC-8,” SOC-8 “did not disclose” that two subjects of the study committed suicide during the observation period or “discuss … how they might undermine SOC-8’s conclusion that pediatric medical transition improved psychological well-being.”

Finally, the complaint alleges that WPATH’s guidelines discourage clinicians from exploring other “numerous potential root causes of a child’s distress about or discomfort with their sex traits,” such as sexual assault or other mental illnesses. Although it acknowledges that such intervening factors do exist, SOC-8 attacks them as “gatekeeping practices” that act as a “barrier to the provision of” transgender procedures.

“Even if WPATH legitimately encouraged clinicians to investigate whether medical transition treatment is appropriate for a given child, SOC-8 offers no genuine method for making such a determination,” the complaint continued. “Indeed, WPATH defines ‘gender incongruence’ as a subjective ‘experience’ that is ‘deeply felt’ by the child. It offers no objective diagnosis criteria for clinicians,” even though “SOC-8 purports to require rigorous diagnostic procedures.” So much for following the science.

These accusations raise an important question: what would motivate the physicians associated with WPATH to venture so far from established science. Beyond the obvious ideological reasons, the complaint focuses on another motive: profit.

“WPATH misrepresents scientific and medical consensus and makes false, deceptive, or unsubstantiated claims regarding pediatric medical transition and related services for a simple reason: WPATH’s members generate significant profit because of the organization’s representations and guidance,” it declared. “Two of the five current members of WPATH’s executive committee are surgeons who specialize in medical transition procedures, and a third member specializes in medical transition procedures for children.”

As a result of WPATH’s non-scientific, profit-motivated guidelines, the complaint continued, children and their families were misled and thereby harmed. “WPATH’s assertions that its recommendations represent evidence-based and “consensus-based expert opinion” give members and other clinicians the means to misrepresent to consumers that the SOC reflects expert scientific consensus,” it argued, “and to repeat the unsubstantiated statements therein when persuading parents and children.”

Whether they visit a family doctor with no specialized training, a gender transition specialist, or an activist center, “children and parents are unlikely to avoid being influenced by WPATH’s deceptive claims and omissions. Indeed, WPATH board member and former president Dr. Marci Bowers claims that ‘the vast majority of mental health providers in the country that [Dr. Bowers is] familiar with follow the WPATH standards of care.’”

“Clinicians begin selling parents and children on medical transition procedures once they arrive at a medical transition provider’s clinic,” the complaint explained. “Sometimes, clinicians make the sale by directly invoking WPATH’s name and providing parents with the SOC or other material containing WPATH’s deceptive claims. Other times, clinicians repeat WPATH’s deceptive claims without attribution. And even without telling parents, clinicians often rely on WPATH’s deceptive claims in making diagnoses and recommending treatment.”

The complaint included numerous examples of WPATH’s malign influence:

  • “For example, a pediatric endocrinologist in California told a pediatric patient's mother that he follows the recommendations of WPATH. When the patient’s mother asked for supporting studies and other evidence for medical transition, the doctor sent her a web link directly to WPATH’s SOC-7, which she then read.
  • “Boston Children’s Hospital Center for Gender Surgery cited ‘WPATH standards of care’ on its page advertising breast implants for children.
  • “One online medical transition clinic asserts that it follows SOC-8 and promises to provide monthly prescriptions for transition services without an in-person visit, covered by major US insurers. It asserts that ‘puberty blockers are fully reversible’ and that ‘children can begin their medical transition with puberty blockers.’
  • “Stanford Medicine’s Transgender Surgery team promises that it ‘follows the World Professional Association for Transgender Health (WPATH) guidelines to ensure patients are appropriate surgical candidates.’
  • “One 13-year-old girl visited a Dallas, Texas clinic with her parents. A psychologist who has presented at WPATH conferences told the girl’s parents that their daughter needed to undergo medical transition, including cross-sex hormones and breast amputation. When these parents expressed skepticism and asked how the psychologist ‘knew that medical transition would help’ their daughter’s distress, the psychologist ‘answered that WPATH recommended it.’
  • “One doctor at a large public university encouraged one 15-year-old patient to read the SOC. The girl, who was later prescribed testosterone and had her breasts amputated, believed based on her interaction with the doctor that WPATH was an official, authoritative medical organization.
  • “A nurse, who worked at Texas Children’s Hospital, recalls that a pediatric endocrinologist at that hospital recorded in patient charts that he ‘told parents he was following WPATH’s Standards of Care’ and ‘explained WPATH’s Standards of Care’ to parents. This doctor ‘frequently referenced WPATH’ when communicating with parents.”

“Clinicians emphasize the need for pediatric medical transition by stating or strongly implying that if parents do not consent to medical transition, their children will commit suicide. Some clinicians tell parents that if their children die, the parents will be to blame. Clinicians often ask parents if they would ‘rather have a dead son or a living daughter,’ or vice versa,” the complaint added. “Clinicians make these statements because WPATH represents that medical transition is ‘lifesaving’ and SOC-8 expressly represents that medical transition is ‘medically necessary’ and reduces suicidality, thereby providing clinicians with the rationale that they use to pressure parents into consenting.”

The complaint provided another half dozen examples of this practice.

“Collectively, WPATH’s deceptive statements and material omissions cause parents to worry that their children are in mortal peril and that the only effective solution is to consent to pediatric medical transition,” it stated. “In many cases, the pressure created by WPATH’s unlawful conduct — and the fear it creates — causes parents to purchase pediatric medical transition drugs, surgeries, or services.”

For years, WPATH was cited not only in doctor’s offices but also in state houses. As some 27 states moved to pass legislation protecting minors from the irreversible effects of gender transition procedures, pro-transgender activists always lined up to appeal to WPATH as experts, citing the “scientific consensus” that “gender-affirming care” was “medically necessary” and “life-saving.” But the evidence never lived up to the buzzwords, and now the FTC is taking WPATH to task.

“Children, but especially their parents, must have complete and truthful information when making decisions to purchase medical services. … The complaint filed today reflects that same long-standing mandate: when an entity makes a claim about a medical treatment, the claim must be truthful, evidence-based and not misleading,” declared FTC Chairman Andrew Ferguson. “WPATH … made false and unsubstantiated claims regarding the necessity, effectiveness and safety of puberty blockers, hormones and sex-change surgeries.”

‍This article was originally written by Joshua Arnold and published on The Washington Stand. For more content like this, visit Real Life Network.